Three versus six months adjuvant oxaliplatin-based chemotherapy for patients with stage III colon cancer: The French participation to the International Duration Evaluation of Adjuvant chemotherapy (IDEA) project.

被引：1
|
作者：
Andre, Thierry
Bonnetain, Franck
Mineur, Laurent
Bennouna, Jaafar
Desrame, Jerome
Faroux, Roger
Dauba, Jerome
Vernerey, Dewi
Aissat, Nasredine
Louvet, Christophe
Lepere, Celine
Dupuis, Olivier Jean Marie
Becouarn, Yves
Mabro, May
Egreteau, Joelle
Bouche, Olivier
Deplanque, Gael
Ychou, Marc
De Gramont, Aimery
Taieb, Julien
机构：
[1] Hop St Antoine, APHP, Dept Med Oncol, Paris, France
[2] Univ Hosp Besancon, Dept Oncol, Methodol & Qual Life Unit, INSERM,UMR 1098, Besancon, France
[3] French Natl Platform Qual Life & Canc, Besancon, France
[4] Inst St Catherine, Avignon, France
[5] Inst Cancerol Ouest, Nantes, France
[6] Hop Prive Jean Mermoz, Lyon, France
[7] Ctr Hosp Dept Oudairies, La Roche Sur Yon, France
[8] Hop Layne, Dept Gastroenterol, Mt De Marsan, France
[9] CHRU Besancon, Methodol & Qual Life Oncol Unit, Besancon, France
[10] GERCOR, Paris, France
[11] Inst Mutualiste Montsouris, Paris, France
[12] Hop Europeen Georges Pompidou, Paris, France
[13] Clin Victor Hugo, Le Mans, France
[14] Inst Bergonie, Bordeaux, France
[15] Hop Foch, Suresnes, France
[16] Ctr Hosp Bretagne Sud, Lorient, France
[17] CHU Robert Debre, Reims, France
[18] CHU Vaudois, Med Oncol, Lausanne, Switzerland
[19] Inst Reg Canc Montpellier, Montpellier, France
[20] Franco British Inst, Levallois Perret, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.3500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3500
引用
收藏
页数：5
相关论文
共 50 条
  • [11] Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer
    Moretto, Roberto
    Falcone, Alfredo
    Cremolini, Chiara
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (09) : 2652 - 2654
  • [12] Impact of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
    Peixoto, Renata D'Alpino
    Kumar, Aalok
    Speers, Caroline
    Renouf, Daniel John
    Kennecke, Hagen F.
    Lim, Howard John
    Cheung, Winson Y.
    Melosky, Barbara L.
    Gill, Sharlene
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [13] Three versus six months' adjuvant oxaliplatin-based chemotherapy for patients with stage III colon cancer: Per-protocol, subgroups and long-lasting neuropathy results
    Taieb, J.
    Bonnetain, F.
    Mineur, L.
    Bennouna, J.
    Desrame, J.
    Faroux, R.
    Fratte, S.
    Dauba, J.
    Vernerey, D.
    Louvet, C.
    Lepere, C.
    Dupuis, O.
    Becouarn, Y.
    Mabro, M.
    Egreteau, J.
    Bouche, O.
    Deplanque, G.
    Ychou, M.
    de Gramont, A.
    Andre, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [14] Noninferiority of three months versus six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice?
    Formica, Vincenzo
    Zaniboni, Alberto
    Loupakis, Fotios
    Roselli, Mario
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (10) : 2342 - 2350
  • [15] Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
    Gallois, Claire
    Shi, Qian
    Pederson, Levi D.
    Andre, Thierry
    Iveson, Timothy J.
    Sobrero, Alberto F.
    Alberts, Steven
    de Gramont, Aimery
    Meyerhardt, Jeffrey A.
    George, Thomas
    Schmoll, Hans-Joachim E.
    Souglakos, Ioannis
    Harkin, Andrea
    Labianca, Roberto
    Sinicrope, Frank A.
    Oki, Eiji
    Shields, Anthony F.
    Boukovinas, Ioannis
    Kerr, Rachel
    Lonardi, Sara
    Yothers, Greg
    Yoshino, Takayuki
    Goldberg, Richard M.
    Taieb, Julien
    Papamichael, Demetris
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (19) : 2295 - 2305
  • [16] IDEA study (International Duration Evaluation of Adjuvant Chemotherapy) for patients with stage III colon cancer: Possibility of reducing to 3 months treatment for 60% of the patients
    Andre, Thierry
    Taieb, Julien
    BULLETIN DU CANCER, 2018, 105 (06) : 546 - 547
  • [17] Efficacy of oxaliplatin-based adjuvant chemotherapy in older patients with stage III colon cancer: An ACCENT/IDEA pooled analysis of 12 trials
    Gallois, C.
    Shi, Q.
    Meyers, J.
    Andre, T.
    Iveson, T. J.
    Sobrero, A. F.
    Alberts, S.
    de Gramont, A.
    Meyerhardt, J.
    Shields, A. F.
    Georges, T.
    Schmoll, H. J. E-V.
    Souglakos, I.
    Kerr, R.
    Lonardi, S.
    Yothers, G.
    Yoshino, T.
    Goldberg, R.
    Taieb, J.
    Papamichael, D.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S682 - S683
  • [18] Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy
    Eren, Tulay
    Pasaoglu, Lale
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
  • [19] Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
    Ramos-Esquivel, Allan
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (04): : 395 - 395
  • [20] Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
    Grothey, A.
    Sobrero, A. F.
    Shields, A. F.
    Yoshino, T.
    Paul, J.
    Taieb, J.
    Souglakos, J.
    Shi, Q.
    Kerr, R.
    Labianca, R.
    Meyerhardt, J. A.
    Vernerey, D.
    Yamanaka, T.
    Boukovinas, I.
    Meyers, J. P.
    Renfro, L. A.
    Niedzwiecki, D.
    Watanabe, T.
    Torri, V.
    Saunders, M.
    Sargent, D. J.
    Andre, T.
    Iveson, T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1177 - 1188
12345